Athira Pharma Inc reports results for the quarter ended in September - Earnings Summary

LeonaBio

10/11/2022 22:45

* Athira Pharma Inc  ATHA.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of 63 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Athira Pharma Inc's reported EPS for the quarter was a
loss
of 53 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Athira Pharma Inc shares had fallen by 7.1% this
quarter and
lost 78.8% so far this year.
    * The company reported a quarterly loss of $20.74 million.
    * Wall Street's median 12-month price target for Athira
Pharma Inc
is $5.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:45 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.63          -0.53          Beat
 Jun. 30 2022      -0.64          -0.65          Missed
 Mar. 31 2022      -0.55          -0.56          Missed
 Dec. 31 2021      -0.54          -0.45          Beat